CONNECT WITH US
HealthTech

HealthTech

Main Line Health’s Olenoski Says AI Governance Has to Move as Fast as the Technology

HealthSystemCIO logo

Published on

Add as a preferred source on Google
Main Line Health’s Olenoski Says AI Governance Has to Move as Fast as the Technology

Main Line Health SVP and CIO Luke Olenoski explains how his team assigns AI decisions, equips 14,000 staff with AI tools and tracks usage-based costs. Watch below or on YouTube.

A health system that reviews AI on a quarterly governance calendar cannot keep up with the technology’s pace of change, according to Luke Olenoski, SVP and CIO at Main Line Health. On a recent episode of the healthsystemCIO Show, he described how the Philadelphia-area system built its AI program on three pillars: education, policy and regulation, and tracking adoption and use cases. The pillars match the work streams of the AI council Olenoski described to healthsystemCIO in July 2025. He described Main Line Health as a $3 billion integrated network with about 14,000 team members. To keep pace, it settled who decides AI questions and folded AI review into existing intake. It also pushed training through peer networks, so adoption does not wait on the help desk.

The policy pillar carries the least glamour and keeps the organization out of trouble, Olenoski said. Much of that work went into settling decision rights. His team worked with clinical, privacy, compliance and legal leaders to set the rules of the road. They also worked out who decides whether to evaluate a new tool or to switch an external large language model on or off. The pace of change drove that choice. In fact, he estimated that 25 to 40 percent of his daily email connects to AI.

“This is not something where you can just meet quarterly or every six months for governance,” Olenoski said.


Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.